BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20524257)

  • 1. [Development for and clinical trials of molecular targeting drugs].
    Takashima A; Fukuda H; Shibata T
    Gan To Kagaku Ryoho; 2010 May; 37(5):822-7. PubMed ID: 20524257
    [No Abstract]   [Full Text] [Related]  

  • 2. [Front-line drug discovery system for cancer].
    Mizukami T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating patient-centered cancer research and a new era of drug discovery.
    Niederhuber JE
    Oncologist; 2009 Apr; 14(4):311-2. PubMed ID: 19365096
    [No Abstract]   [Full Text] [Related]  

  • 4. The convergence of cancer prevention and therapy in early-phase clinical drug development.
    Abbruzzese JL; Lippman SM
    Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3rd EORTC-NCI International Meeting on Cancer Molecular Markers: From Discovery to Clinical Practice.
    Taube SE; Gion M; Schilsky RL
    Expert Rev Mol Diagn; 2004 Jul; 4(4):431-3. PubMed ID: 15225090
    [No Abstract]   [Full Text] [Related]  

  • 6. Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer Institute.
    Trimble EL; Abrams JS; Ansher SS; Smith MA; Zwiebel JA; Tomaszewski JE
    Future Med Chem; 2010 Apr; 2(4):555-9. PubMed ID: 21426005
    [No Abstract]   [Full Text] [Related]  

  • 7. [New therapeutic strategies in oncology].
    Bohuon C
    Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2003 May; 9(5):1579-89. PubMed ID: 12738709
    [No Abstract]   [Full Text] [Related]  

  • 9. [The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].
    Andoh M; Fujiwara Y; Shimada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):1015-9. PubMed ID: 16878363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K and mTOR inhibitors: a new generation of targeted anticancer agents.
    Brachmann S; Fritsch C; Maira SM; García-Echeverría C
    Curr Opin Cell Biol; 2009 Apr; 21(2):194-8. PubMed ID: 19201591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drug development.
    Cheson BD
    Clin Adv Hematol Oncol; 2009 Sep; 7(9):556. PubMed ID: 20020666
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment evaluation in active control studies.
    Fleming TR
    Cancer Treat Rep; 1987 Nov; 71(11):1061-5. PubMed ID: 3119201
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors influencing development of new therapeutics for oncology.
    Winquist RJ; Boucher DM
    Curr Opin Pharmacol; 2010 Aug; 10(4):353-5. PubMed ID: 20634136
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methodological features of assessing the effectiveness of adjuvant therapy in clinical trials].
    Dvoĭrin VV
    Vopr Onkol; 1986; 32(6):18-22. PubMed ID: 3523991
    [No Abstract]   [Full Text] [Related]  

  • 15. Sometimes size doesn't matter: reevaluating RECIST and tumor response rate endpoints.
    Tuma RS
    J Natl Cancer Inst; 2006 Sep; 98(18):1272-4. PubMed ID: 16985244
    [No Abstract]   [Full Text] [Related]  

  • 16. Food and Drug Administration requirements for approval of new anticancer drugs.
    Johnson JR; Temple R
    Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New oncological drugs].
    Pyrhönen S
    Duodecim; 2000; 116(24):2841-52. PubMed ID: 12077890
    [No Abstract]   [Full Text] [Related]  

  • 18. New targets for cancer chemotherapy.
    Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
    Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting of cancer energy metabolism.
    Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Carreño-Fuentes L; Moreno-Sánchez R
    Mol Nutr Food Res; 2009 Jan; 53(1):29-48. PubMed ID: 19123180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criticism of tumor response criteria raises trial design questions.
    Twombly R
    J Natl Cancer Inst; 2006 Feb; 98(4):232-4. PubMed ID: 16478740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.